Shaily Engineering Plastics Limited — PPTs, 10-02-2025: Investor Presentation

**Financial Highlights:**

Shaily Engineering Plastics reported a strong performance in Q3 FY25 with revenues of ₹197.6 Cr, marking a 25% increase year-over-year, while nine-month revenues reached ₹569.0 Cr, up 20%. Gross profit margins improved to 47.5%, and EBITDA margins increased to 23.4%. Profit After Tax soared to ₹25.2 Cr, representing a 73% increase from the previous year.

**Strategic Initiatives and Growth Drivers:**

The company continues to make strategic enhancements in its healthcare and consumer segments, signing six contracts for Pen Injectors with various clients and securing business from two global retail chains to commence in FY26. Participation in major exhibitions, like Cosmoprof in Mumbai and Pharma Pack in Paris, showcases its capabilities and attracts new business.

**Business Developments:**

Shaily's recent contracts and partnerships indicate an effective push into both healthcare and consumer markets, positioning it favorably for future growth. The focus on innovation in medical devices will likely bolster its competitive edge.

**Market Position and Competitive Advantage:**

Shaily is leveraging its established relationships with marquee clients and expanding its market share through enhanced product offerings and strategic collaborations, presenting a positive outlook for future revenue growth.

**Investor Implications:**

Given the strong financial performance and strategic partnerships, investors should perceive potential growth opportunities. The promising developments in both the healthcare and consumer segments could yield substantial returns in the upcoming quarters, warranting close attention.